Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity
Inflammation and coagulation are key basic mechanism of protection against all potentially pathogenic mechanical and biological factors targeting human organism from inner and outer environment. On the other hand, uncontrolled inflammation results in hypercoagulation, inhibition of anticoagulation a...
Saved in:
| Main Authors: | E. L. Nasonov, T. V. Beketova, T. M. Reshetnyak, A. M. Lila, L. P. Ananieva, T. A. Lisitsyna, S. K. Soloviev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2020-09-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2923 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
by: E. L. Nasonov, et al.
Published: (2021-07-01) -
The place of intravenous immunoglobulin in rheumatic diseases
by: N. V. Seredavkina, et al.
Published: (2016-01-01) -
AUTOIMMUNE RHEUMATIC DISEASES: RESULTS AND PROSPECTS FOR RESEARCHES
by: E. L. Nasonov, et al.
Published: (2015-09-01) -
Inhibition of SARS‐CoV‐2‐mediated thromboinflammation by CLEC2.Fc
by: Pei‐Shan Sung, et al.
Published: (2023-05-01) -
Stressors and depressive disorders in rheumatic diseases
by: Tatyana Andreyevna Lisitsyna, et al.
Published: (2013-04-01)